We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 21-40 of 10,000 results

  1. Glofitamab therapy for diffuse large B cell lymphoma: latest updates from the 2022 ASH Annual Meeting

    Over one-third of B cell lymphomas are not effectively treated by R-CHOP chemotherapy. When lymphoma relapses or is refractory, the prognosis becomes...

    Chaoyu Wang, Yao Liu in Journal of Hematology & Oncology
    Article Open access 10 March 2023

  2. New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting

    Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue...

    Matthieu Roulleaux-Dugage, Antoine Italiano in Journal of Hematology & Oncology
    Article Open access 08 August 2023

  3. Current Practice Trends in Knee Arthroplasty in India Among ISHKS Members: ISHKS Annual Meeting 2019

    Aim

    To assess the current practice trends in knee arthroplasty in India among ISHKS members.

    Methods

    Literature review on 12 areas of key interest in...

    Arun Mullaji, Dhanasekara Raja Palanisami, Pachore Javahir Anant in Indian Journal of Orthopaedics
    Article 02 September 2023

  4. BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting

    Treatment of relapsed and/or refractory multiple myeloma (RRMM) utilizing the novel therapeutic target of the B-cell maturation antigen (BCMA) has...

    James F. Wu, Binod Dhakal in Journal of Hematology & Oncology
    Article Open access 28 July 2023

  5. Targeted treatment of T-cell acute lymphoblastic leukemia: latest updates from the 2022 ASH Annual Meeting

    T-cell acute lymphoblastic leukemia (T-ALL) occurs in approximately 25–30% of adult ALL. Currently, treatment approaches for adult patients with...

    Jieyu Xu, Hong-Hu Zhu in Experimental Hematology & Oncology
    Article Open access 11 March 2023

  6. Novel agents and regimens in acute myeloid leukemia: latest updates from 2022 ASH Annual Meeting

    Developments in investigational agents and novel regimens in acute myeloid leukemia (AML) were reported in the 2022 American Society of Hematology...

    Katherine W. DiNardo, Thomas W. LeBlanc, Hui Chen in Journal of Hematology & Oncology
    Article Open access 03 March 2023

  7. CAR T cell therapy for T cell leukemia and lymphoma: latest updates from 2022 ASH Annual Meeting

    Due to the concern of fratricide, clinical development of CAR T cells for the therapy of T cell malignancies lags behind that for B cell...

    Qiusha Huang, **ao-hui Zhang, Delong Liu in Journal of Hematology & Oncology
    Article Open access 05 March 2023

  8. Ovarian cancer—ASCO annual meeting update 2021

    The 2021 ASCO annual meeting did not change clinical practice in the treatment of ovarian cancer, but several interesting studies were presented that...

    Johannes Schöche, Kathrin Strasser-Weippl in memo - Magazine of European Medical Oncology
    Article 21 October 2021

  9. Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting

    Bispecific antibodies (BsAbs) and dual-targeted chimeric antigen receptor T (CAR T) cells have been employed in relapsed/refractory multiple myeloma...

    Jiangxue Hou, Yufu Li, Quande Lin in Experimental Hematology & Oncology
    Article Open access 26 August 2023

  10. Paediatric syndromic scoliosis: proceedings of the half-day course at the 57th annual meeting of the Scoliosis Research Society

    There are some syndromes that present with unique manifestations pertaining to the spinal column. A good working understanding of these common...

    Jwalant S. Mehta, Joshua M. Pahys, ... Greg Redding in Spine Deformity
    Article 16 February 2024

  11. Off-the-shelf CAR-T cell therapies for relapsed or refractory B-cell malignancies: latest update from ASH 2023 annual meeting

    Currently, many off-the-shelf chimeric antigen receptor (CAR)-T cell products are under investigation for the treatment of relapsed or refractory...

    Yun Kang, Chenggong Li, Heng Mei in Journal of Hematology & Oncology
    Article Open access 06 May 2024

  15. Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting

    Recent evidence suggests that bispecific antibodies (BsAbs) exhibit promising efficacy and low toxicity even in heavily treated non-Hodgkin B-cell...

    Zhijuan Lin, Long Liu, ... Bing Xu in Experimental Hematology & Oncology
    Article Open access 21 April 2023

  17. Twenty Years of SPARTAN: From Inception to Impact (SPARTAN 2023 Annual Meeting Proceedings)

    Purpose of Review

    This review takes a look at the past, present, and future of SPARTAN, the Spondyloarthritis Research and Treatment Network, an...

    Joerg Ermann, Atul Deodhar, ... John D. Reveille in Current Rheumatology Reports
    Article 12 January 2024
Did you find what you were looking for? Share feedback.